GLOBUS MEDICAL, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $10.97M, a 133.57% increase year-over-year.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $25.96M, a 131.32% increase year-over-year.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $11.08M, a 52.87% decline year-over-year.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $4.70M, a 67.01% decline year-over-year.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $89.76M, a 18.73% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $110.44M, a 790.93% increase from fiscal 2023.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $12.40M, a 70.28% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $41.72M, a 34.30% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $10.97M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $25.96M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $89.76M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $11.08M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.70M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $11.22M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $110.44M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $23.50M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $14.24M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $3.41M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $12.40M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $3.30M 10-Q · filed 2024-11-05 | $26.85M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $3.20M 10-Q · filed 2024-11-05 | $38.44M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-03-31 | $4.86M 10-Q · filed 2024-11-05 | $38.83M derived: sum of 4 quarters · filed 2024-11-05 |
| 2022-12-31 | $15.49M 10-K · filed 2023-02-21 | $41.72M 10-K · filed 2025-02-20 |
| 2022-09-30 | $14.89M 10-Q · filed 2023-11-07 | $29.79M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $3.58M 10-Q · filed 2023-11-07 | $39.23M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-03-31 | $7.75M 10-Q · filed 2023-11-07 | $62.14M derived: sum of 4 quarters · filed 2023-11-07 |
| 2021-12-31 | $3.56M 10-K · filed 2023-02-21 | $63.50M 10-K · filed 2024-02-21 |
| 2021-09-30 | $24.34M 10-K · filed 2023-02-21 | $88.14M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $26.50M 10-K · filed 2023-02-21 | $91.96M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $9.10M 10-K · filed 2023-02-21 | $75.66M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $28.20M 10-K · filed 2023-02-21 | $72.32M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-09-30 | $28.16M 10-K · filed 2023-02-21 | $55.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-06-30 | $10.20M 10-K · filed 2023-02-21 | $34.73M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-03-31 | $5.76M 10-K · filed 2023-02-21 | $26.55M derived: sum of 4 quarters · filed 2023-02-21 |
| 2019-12-31 | $11.68M 10-K · filed 2022-02-17 | $31.04M 10-K/A · filed 2020-03-02 |
| 2019-09-30 | $7.08M 10-K · filed 2022-02-17 | $22.42M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-06-30 | $2.02M 10-K · filed 2022-02-17 | $18.45M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-03-31 | $10.26M 10-K · filed 2022-02-17 | $40.26M derived: sum of 4 quarters · filed 2022-02-17 |
| 2018-12-31 | $3.07M 10-K · filed 2021-02-17 | $39.31M 10-K/A · filed 2020-03-02 |
| 2018-09-30 | $3.11M 10-K · filed 2021-02-17 | $41.04M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-06-30 | $23.82M 10-K · filed 2021-02-17 | $38.96M derived: sum of 4 quarters · filed 2021-02-17 |
| 2018-03-31 | $9.31M 10-K · filed 2021-02-17 | $19.05M derived: sum of 4 quarters · filed 2021-02-17 |
| 2017-12-31 | $4.79M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $11.73M 10-K/A · filed 2020-03-02 |
| 2017-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $8.39M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.21M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $1.99M 10-Q · filed 2017-05-04 | $5.97M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $5.87M 10-K · filed 2019-02-21 |
| 2016-09-30 | $853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $5.59M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $6.04M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $1.90M 10-Q · filed 2016-05-04 | $5.95M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $5.48M 10-K · filed 2018-02-22 |
| 2015-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $6.41M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $6.12M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $1.43M 10-Q · filed 2015-05-05 | $7.31M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $9.74M 10-K · filed 2017-03-16 |
| 2014-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $8.98M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $9.93M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $3.85M 10-Q · filed 2014-04-30 | $10.53M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $7.55M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $6.68M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | |
| 2013-03-31 | $885.00K 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $1.50M 10-K · filed 2015-02-26 |
| 2011-12-31 | $742.00K 10-K · filed 2014-03-14 | |
| 2010-12-31 | $1.29M 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |